Selenium substitution during radiotherapy of solid tumours - Laboratory data from two observation studies in gynaecological and head and neck cancer patients

Anticancer Research

Volumn 30, Issue 5, 2010, Pages 1783-1786

  Büntzel, Jens ^a   Micke, Oliver ^b   Kisters, Klaus ^c   Bruns, Frank ^d   Glatzel, Michael ^e   Schönekaes, Klaus ^c   Kundt, Günther ^f   Schäfer, Ulrich ^g   Mücke, Ralph ^g  

^a Sudharz Krankenhaus Nordhausen   (Germany)

^b FRANZISKUS HOSPITAL   (Germany)

^c German Study Group Trace Elements and Electrolytes in Oncology (AKTE)   (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e Zentralklinikum ^*  (Germany)

^f UNIVERSITY OF ROSTOCK   (Germany)

^g KLINIKUM LIPPE DETMOLD   (Germany)

Author keywords

Radiotherapy; Selenium substitution; Solid tumours

Indexed keywords

SODIUM SELENITE;

ADULT; BLOOD LEVEL; CONFERENCE PAPER; CONTROLLED STUDY; GYNECOLOGIC CANCER; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REFERENCE VALUE; SELENIUM BLOOD LEVEL; SELENIUM DEFICIENCY; SOLID TUMOR; TUMOR LOCALIZATION;

AGED; DRUG ADMINISTRATION SCHEDULE; FEMALE; FREE RADICALS; GENITAL NEOPLASMS, FEMALE; GLUTATHIONE PEROXIDASE; HEAD AND NECK NEOPLASMS; HUMANS; MIDDLE AGED; RADIOTHERAPY; SODIUM SELENITE; SPECTROPHOTOMETRY, ATOMIC; TRACE ELEMENTS; TREATMENT OUTCOME;

EID: 77954607733     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (8)

1. Pleban PA, Munyani A and Beachum J: Determination of selenium concentration and glutathione peroxidase activity in plasma and erythrocytes. Clinical Chemistry 28: 311-316, 1982. (Pubitemid 12184398)
2. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RS and Gluud C: Mortality in randomized trials of antioxidant supplements for primary and secondary prevention. JAMA 297: 842-857, 2007.
3. Brizel DM and Overgaard J: Does amifostine have a role in chemoradiation treatment? Lancet Oncol 4: 378-381, 2003.
4. Mücke R, Glatzel M, Berndt-Skorka R, Baaske D, Reichl B, Büntzel J, Kundt G, Pratt F, de Vries A and Micke O: Multicenter, phase III study comparing selenium supplementation with observation in gynecologic radiation oncology. J Clin Oncol 26: May 20 suppl; abstr 9539, 2008.
5. Büntzel J, Riesenbeck D, Glatzel M, Berndt-Skorka R, Riedel T, Micke O, Mücke R, Kisters K, Schönekaes KG, Schäfer U and Bruns F: Effects of selenium substitution in the prevention of radiation-associated toxicities - results of a randomized study in head and neck cancer patients. AKTE Band 10, Diplodochus Bielefeld, pp. 44-49, 2008.
6. Büntzel J, Micke O, Mücke R, Glatzel M, Schönekaes KG, Schäfer U, Kisters K and Bruns F: Amifostine and selenium during simultaneous radiochemotherapy in head and neck cancer - redox status data. Trace Elem Electrol 22: 211-215, 2005. (Pubitemid 41020161)
7. Büntzel J, Micke O, Adamietz IA, Monnier A, Glatzel M and de Vries A: Intravenous amifostine during chemoradiotherapy for head-and-neck cancer. A randomized placebo-controlled phase III study. Int J Radiat Oncol Biol Phys 64: 684-691, 2006. (Pubitemid 43183561)
8. Schomburg L: Zur physiologischen Bedeutung des Selenstatus und des Selentransport- und Speicherproteins SePP. AKTE Band 10, Diplodochus Bielefeld, pp. 8-13, 2008.